Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

NEWS

US CDC tracks new lineage of virus that causes COVID

US CDC tracks new lineage of virus that causes COVID

US CDC tracks new lineage of virus that causes COVID

By Deena Beasley

(Reuters) – U.S. Centers for Disease Control and Prevention said on Thursday that it was tracking a new, highly mutated lineage of the virus that causes COVID-19.

The lineage is named BA.2.86, and has been detected in the United States, Denmark and Israel, the CDC said in a post on messaging platform X.

“As we learn more about BA.2.86, CDC’s advice on protecting yourself from COVID-19 remains the same,” the agency said.

The World Health Organization (WHO) earlier on Thursday said in a post on X that it had classified BA.2.86 as a “variant under monitoring” due to the large number of mutations it carries.

The WHO said that, so far, only a few sequences of the variant have been reported from a handful of countries.

The new lineage, which has 36 mutations from the currently-dominant XBB.1.5 COVID variant “harkens back to an earlier branch” of the virus, explained Dr. S. Wesley Long, medical director of diagnostic microbiology at Houston Methodist.

He said it remains to be seen whether BA.2.86 will be able to out-compete other strains of the virus or have any advantage in escaping immune responses from prior infection or vaccination.

Early analysis indicates that the new variant “will have equal or greater escape than XBB.1.5 from antibodies elicited by pre-Omicron and first-generation Omicron variants,” Jesse Bloom, a virologist at the Fred Hutchinson Cancer Center said in a slide deck published on Thursday.

The Omicron subvariant XBB.1.5 is the strain targeted by vaccines in upcoming COVID booster shots.

Bloom’s slides note that the most likely scenario is that BA.2.86 is less transmissible than current dominant variants, so never spreads widely, but more sequencing data is needed.

“My biggest concern would be that it could cause a bigger spike in cases than what we have seen in recent waves,” Dr. Long said. “The boosters will still help you fight off COVID in general.”

 

(This story has been corrected to fix the name of the COVID variant to XBB.1.5 in paragraphs 6 and 8, the name of Fred Hutchinson Cancer Center in paragraph 8, and typos for BA.2.86 in paragraph 7)

 

(Reporting by Shivani Tanna in Bengaluru; Editing by Himani Sarkar & Simon Cameron-Moore)

 

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts